CIK 0001599298 · Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 371979717
- Phone
- 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Co-Chief Executive Officer bought 338,394 shares at an average $17.69 ($5,984,756)
- 4 Open-market buy Co-Chief Executive Officer bought 338,394 shares at an average $17.69 ($5,984,756)
- 4 Option exercise Co-Chief Executive Officer acquired 74,545 shares (option exercise)
- 4 Option exercise Co-Chief Executive Officer acquired 74,545 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Co-Chief Executive Officer acquired 3,985,055 shares (option exercise)
- 4 Option exercise Co-Chief Executive Officer acquired 3,985,055 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 7 · 130 filings